Another shot that belongs in the dumpster because it cannot stop transmission!
Health chiefs have warned people to watch out for monkeypox breakthrough infections.
The pathogen is ‘evading’ the shot.
Oh look more medicine that doesn’t work 👇 pic.twitter.com/MLNLoq4R11
— Weaponized News (@WeaponizedNews) August 23, 2022
We’ve heard this story once before with the experimental COVID-19 injections.
The monkeypox (smallpox) shot appears to be another worthless injection that only comes with potential adverse reactions.
Monkeypox reportedly continues to spread across the globe and medics warned the ‘vaccines’ aren’t a ‘silver bullet.’
Is this another shot that supposedly relieves symptoms instead of preventing infection?
From the U.S. Sun:
Now, chiefs at the World Health Organisation (WHO) have warned that there has been a number of breakthrough cases of the bug.
This means that people who are vaccinated – are still catching the illness.
Dr Rosamund Lewis, WHO’s technical lead for monkeypox, said these infections have been seen in people who had a prophylaxis vaccine following exposure to the virus.
“We have known from the beginning that this vaccine would not be a silver bullet, that it would not meet all the expectations that are being put on it and that we don’t have firm efficacy data or effectiveness data in this context.
“The fact that we’re beginning to see some breakthrough cases is also really important information because it tells us that the vaccine is not 100% effective in any given circumstance, whether preventive or post-exposure.
“We cannot expect 100 per cent effectiveness at the moment based on this emerging information,” she told a press briefing.
Advisory Board added:
So far, much of the data on the monkeypox vaccine is from a retrospective analysis published in 1988, which examined whether a smallpox vaccine could also prevent monkeypox. In the study, researchers followed household contacts of 209 people in Zaire who had been infected with monkeypox and found that those who had scars from prior smallpox vaccination were 85% less likely to be infected.
In addition, immunological studies in humans have shown that the vaccine generates monkeypox antibodies in people’s blood—but the level of protection is not currently known.
“So we know that the vaccine does stimulate the immune system and people produce antibodies when they receive the vaccine,” said Boghuma Titanji, an infectious disease specialist at Emory University, “but we don’t have a clinical data in humans to actually tell us, ‘Okay, that immune response translates to this level of protection against getting infected with monkeypox or reducing the severity of monkeypox disease if you do get infected.'”
Currently, WHO has called for international studies on the monkeypox vaccine to better determine its efficacy in the ongoing outbreak.
The WHO previously admitted that recipients of the monkeypox (smallpox) shot are part of a ‘clinical trial’ to collect data on its effectiveness.